Finance

Lists
Q2 2027 earnings • released • Revenue beat +1.40%
See results
2802:TYO
Ajinomoto Co Inc
¥4,260.00
-0.09%
(-4.00) 1D
Nov 12, 3:24:59 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2802...
Open
¥4,264
High
¥4,345
Low
¥4,247
Mkt. cap
4.17T
Avg. vol.
4.03M
Volume
6.59M
Dividend
1.13%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
26.09
52-wk high
¥6,340
52-wk low
¥3,270
EPS
¥163
Shares outstanding
537.42M
No. of employees
35K
Open
¥4,264
High
¥4,345
Low
¥4,247
Mkt. cap
4.17T
Avg. vol.
4.03M
Volume
6.59M
Dividend
1.13%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
26.09
52-wk high
¥6,340
52-wk low
¥3,270
EPS
¥163
Shares outstanding
537.42M
No. of employees
35K
News stories
From web sources and news partners
Profile
Ajinomoto Co., Inc. is a Japanese multinational food and biotechnology corporation which produces seasonings, cooking oils, frozen foods, beverages, sweeteners, amino acids, insulating films, and pharmaceuticals. Aji-No-Moto is the trade name for the company's original monosodium glutamate product, the first of its kind, since 1909. The corporation's head office is located in Chūō, Tokyo. As of 2024, Ajinomoto operates in 31 countries worldwide and employs an estimated 34,862 people. Its yearly revenue in 2024 is around ¥1.53 trillion JPY or $10.61 billion USD. Wikipedia
About Ajinomoto Co Inc
CEOShigeo Nakamura
Employees34.8K
FoundedMay 20, 1909
HeadquartersChuo City, Tokyo, Japan
SectorConsumer Staples
IndustryFood
Websiteajinomoto.co.jp
Last report
Nov 9, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
419.06B / 413.26B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
374.87B
425.29B
419.55B
412.10B
Cost of goods sold
234.45B
259.36B
267.76B
247.48B
Cost of revenue
234.45B
259.36B
267.76B
247.48B
Research and development expenses
7.84B
7.90B
9.03B
7.97B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94.47B
100.87B
109.10B
99.23B
Operating expense
109.34B
111.07B
123.49B
111.42B
Total operating expenses
343.79B
370.43B
391.25B
358.90B
Operating income
31.08B
54.86B
28.30B
53.21B
Other non operating income
1.00M
-1.00M
-855.00M
-3.00M
EBT including unusual items
32.02B
56.87B
59.16B
54.99B
EBT excluding unusual items
32.02B
56.87B
30.87B
54.99B
Income tax expense
10.21B
15.77B
11.93B
15.68B
Effective tax rate
31.89%
27.73%
20.16%
28.51%
Other operating expenses
7.03B
2.30B
5.32B
4.22B
Net income
19.03B
38.50B
44.93B
36.45B
Net profit margin
5.08%
9.05%
10.71%
8.85%
Earnings per share
-
-
-
-
Interest and investment income
2.05B
2.76B
507.00M
2.43B
Interest expense
-2.51B
-2.83B
-
-3.33B
Net interest expenses
-467.00M
-74.00M
507.00M
-901.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
52.82B
77.37B
51.94B
76.70B
Gain or loss from assets sale
1.94B
656.00M
-29.20B
941.00M
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps